Evidence map›Paper›PMID 16504021›Full record

ArticleCell communication and signaling : CCS2006

NOV story: the way to CCN3.

Bernard Perbal

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. The CCN family of proteins: a 25th anniversary picture.Journal of cell communication and signaling · 2016
    Article
  5. Article
  6. Article
  7. Cooperative regulation of chondrocyte differentiation by CCN2 and CCN3 shown by a comprehensive analysis of the CCN family proteins in cartilage.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2008
    Article
  8. Review
  9. CCN3: Doctor Jekyll and Mister Hyde.Journal of cell communication and signaling · 2008
    Article
  10. CCN3-mutant mice are distinct from CCN3-null mice.Journal of cell communication and signaling · 2007
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Bernard PerbalLaboratoire d'Oncologie Virale et Moléculaire, Case 7048, UFR de Biochimie, Université Paris 7 - D, Diderot, 2 place Jussieu, 75005 Paris-France. perbal@ccr.jussieu.fr

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The principal aim of this historical review- the first in a new series- is to present the basic concepts that led to the discovery of NOV and to show how our ideas evolved regarding the role and functions of this new class of proteins. It should prove particularly useful to the new comers and to students who are engaged in this exciting field. It is also a good opportunity to acknowledge the input of those who participated in the development of this scientific endeavour.

Identifiers

PMID16504021
PMCPMC1434737

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.